MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 10, 2008; DOI: 10.1124/mol.108.050773


0026-895X/08/7406-1554-1563$20.00
Mol Pharmacol 74:1554-1563, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.050773v1
74/6/1554    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fruchart-Gaillard, C.
Right arrow Articles by Servent, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fruchart-Gaillard, C.
Right arrow Articles by Servent, D.

Different Interactions between MT7 Toxin and the Human Muscarinic M1 Receptor in Its Free and N-Methylscopolamine-Occupied States

Carole Fruchart-Gaillard, Gilles Mourier, Catherine Marquer, Enrico Stura, Nigel J. M. Birdsall, and Denis Servent

Commissariat à l'Energie Atomique, Institut de Biologie et de Tecnologies de Saclay, Service d'Ingénierie Moléculaire des Protéines, Laboratoire de Toxinologie Moléculaire et Biotechnologie, Gif sur Yvette, France (C.F.-G, G.M., C.M., E.S., D.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, Mill Hill, London, United Kingdom (N.J.M.B.)

Muscarinic MT7 toxin is a highly selective and potent antagonist of the M1 subtype of muscarinic receptor and acts by binding to an allosteric site. To identify the molecular determinants by which MT7 toxin interacts with this receptor in its free and NMS-occupied states, the effect on toxin potency of alanine substitution was evaluated in equilibrium and kinetic binding experiments as well as in functional assays. The determination of the crystallographic structure of an MT7-derivative (MT7-diiodoTyr51) allowed the selection of candidate residues that are accessible and present on both faces of the three toxin loops. The equilibrium binding data are consistent with negative cooperativity between N-methylscopolamine (NMS) and wild-type or modified MT7 and highlight the critical role of the tip of the central loop of the toxin (Arg34, Met35 Tyr36) in its interaction with the unoccupied receptor. Examination of the potency of wild-type and modified toxins to allosterically decrease the dissociation rate of [3H]NMS allowed the identification of the MT7 residues involved in its interaction with the NMS-occupied receptor. In contrast to the results with the unoccupied receptor, the most important residue for this interaction was Tyr36 in loop II, assisted by Trp10 in loop I and Arg52 in loop III. The critical role of the tips of the MT7 loops was also confirmed in functional experiments. The high specificity of the MT7-M1 receptor interaction exploits several MT7-specific residues and reveals a different mode of interaction of the toxin with the free and NMS-occupied states of the receptor.


Received for publication July 23, 2008.

Accepted for publication September 10, 2008.

Address correspondence to: D. Servent, CEA, iBiTecS, Service d'Ingénierie Moléculaire des Protéines (SIMOPRO), Laboratoire de Toxinologie Moléculaire et Biotechnologie, Gif sur Yvette, F-91191, France. E-mail: denis.servent{at}cea.fr







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics